255 related articles for article (PubMed ID: 11511902)
1. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
4. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
[TBL] [Abstract][Full Text] [Related]
5. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
6. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
7. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
10. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.
Kaminogo M; Ishimaru H; Morikawa M; Ochi M; Ushijima R; Tani M; Matsuo Y; Kawakubo J; Shibata S
Neuroradiology; 2001 May; 43(5):353-63. PubMed ID: 11396738
[TBL] [Abstract][Full Text] [Related]
12. Effect of voxel position on single-voxel MR spectroscopy findings.
Ricci PE; Pitt A; Keller PJ; Coons SW; Heiserman JE
AJNR Am J Neuroradiol; 2000 Feb; 21(2):367-74. PubMed ID: 10696025
[TBL] [Abstract][Full Text] [Related]
13. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
15. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopy of pediatric cerebellar tumors.
Wang Z; Sutton LN; Cnaan A; Haselgrove JC; Rorke LB; Zhao H; Bilaniuk LT; Zimmerman RA
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1821-33. PubMed ID: 8693982
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
[TBL] [Abstract][Full Text] [Related]
18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]